Stockscreener 앱 받기
2.72
1.12%
0.03
전일 마감가:
$2.69
열려 있는:
$2.69
하루 거래량:
30,053
Relative Volume:
0.05
시가총액:
$4.87M
수익:
$9.26M
순이익/손실:
$-941.60K
주가수익비율:
-37.78
EPS:
-0.072
순현금흐름:
$-2.65M
1주 성능:
+0.37%
1개월 성능:
+15.94%
6개월 성능:
-25.15%
1년 성능:
-54.97%
1일 변동 폭
$2.65
$2.85
1주일 범위
$2.59
$3.0677
52주 변동 폭
$2.0068
$8.40
Bionexus Gene Lab Corp Stock (BGLC) Company Profile
명칭
Bionexus Gene Lab Corp
전화
1-307-241-6898
주소
10-2 TOWER B, VERTICAL BUSINESS SUITE,, KUALA LUMPUR
BGLC을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BGLC
BioNexus Gene Lab Corp Common stock
|
0.343 | 201.51M | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
20.26 | 372.90M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.1555 | 349.69M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
MOBBW
Mobilicom Limited Warrants
|
0.2267 | 318.40M | 0 | 0 | 0 | 0.00 |
|
JUNE
Dhandho Junoon Etf
|
11.00 | 205.55M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
4.11 | 157.18M | 0 | 0 | 0 | 0.00 |
Bionexus Gene Lab Corp 주식(BGLC)의 최신 뉴스
BioNexus Gene Lab Corp Regains Nasdaq Compliance With $1.00 Minimum Bid Price - marketscreener.com
Bionexus Gene Lab regains Nasdaq compliance - TipRanks
BioNexus Gene Lab regains Nasdaq compliance By Investing.com - Investing.com India
BioNexus Gene Lab regains Nasdaq compliance - Investing.com
BioNexus Gene Lab Corp. Regains Nasdaq Compliance, Signaling Strategic Stability and Growth Readiness - The Manila Times
BioNexus Gene Lab Corp. Regains Compliance with Nasdaq Listing Rule and Enhances Growth Strategy - Nasdaq
BioNexus Gene Lab Secures Future with Nasdaq Compliance Win: Strategic Expansion Plans Revealed - Stock Titan
BioNexus Gene Lab Corp SEC 10-K Report - TradingView
BioNexus Gene Lab Corp. Files 2024 Annual Report Highlighting Strategic Innovation, Operational Resilience, and Growth Trajectory - The Manila Times
BioNexus Gene Lab Corp. Files 2024 Annual Report Highlighting Strategic Innovation, Operational - Bluefield Daily Telegraph
BioNexus Slashes Losses by 39%: Inside the Biotech's Strategic Pivot to Blockchain and AI - Stock Titan
3 Penny Stocks to Watch Now, 4/15/25 - TipRanks
12 Industrials Stocks Moving In Monday's Pre-Market Session - Benzinga
12 Industrials Stocks Moving In Friday's Intraday Session - Benzinga
BioNexus Gene Lab Corp: Surge Insights - timothysykes.com
12 Industrials Stocks Moving In Friday's Pre-Market Session - Benzinga
Why BioNexus Gene Stock Jumps 55% in Premarket Trading - Own Snap
BioNexus Gene Lab enacts reverse stock split - Investing.com
BioNexus Gene Lab enacts reverse stock split By Investing.com - Investing.com India
BGLC stock touches 52-week high of $2.35 amid market fluctuations - Investing.com Australia
BGLC stock touches 52-week high of $2.35 amid market fluctuations By Investing.com - Investing.com South Africa
12 Industrials Stocks Moving In Thursday's Intraday Session - Benzinga
BioNexus Gene Lab announces reverse stock split - Investing.com Australia
BioNexus Gene Lab announces reverse stock split By Investing.com - Investing.com South Africa
12 Industrials Stocks Moving In Monday's After-Market Session - Benzinga
12 Industrials Stocks Moving In Thursday's After-Market Session - Benzinga
Why Greenland Technologies Shares Are Trading Higher By Around 89%; Here Are 20 Stocks Moving Premarket - Benzinga
12 Industrials Stocks Moving In Wednesday's After-Market Session - Benzinga
12 Industrials Stocks Moving In Friday's After-Market Session - Benzinga
Bionexus Gene Lab enters partnership with ML Tech - Yahoo Finance
BioNexus Gene Lab Taps ML Tech for AI-Driven Ethereum Growth - tokenpost.com
BioNexus Gene Lab Corp and ML Tech Partner to Enhance Ethereum-focused Treasury Strategy - The Manila Times
Continued Unit Revenue Growth - The Manila Times
BioNexus Gene Lab partners with ML Tech to optimize Ethereum growth strategies - Investing.com
Can AI Transform Corporate Ethereum Management? BioNexus Thinks So - StockTitan
Full Stock Market News from 2025-03-07 - StockTitan
BioNexus Pivots Ethereum as Primary Treasury Asset - Tekedia
Ethereum price forecast: Liquidity conditions to dictate direction amid sour sentiment - TU News
@0x1Tax - Binance
Bionexus Gene Lab Corp Makes History With Ethereum-Focused Treasury Strategy - Binance
Ethereum ETF Flows Fluctuate as Market Uncertainty Continues - The Currency Analytics
BioNexus Gene Lab Becomes First Nasdaq-Listed Firm to Prioritize Ethereum in Treasury Strategy - idfspokesperson.com
This Nasdaq company chooses Ethereum as a strategic reserve - Passionategeekz
Ethereum addresses containing more than 10,000 ETH decline significantly - TU News
WLFI boosts $10 million in ETH and $10 million in Wrapped Bitcoin for week - TU News
BioNexus Gene Lab becomes first public company with Ethereum reserves - Traders Union
Bionexus Gene Lab becomes the first Nasdaq-Genter company that embraces Ethereum as Treasury Asset - Passionategeekz
BioNexus Gene Lab Becomes First Nasdaq-Listed Company to Embrace Ethereum as Treasury Asset - BeInCrypto
Ethereum ETF flows fluctuate – What’s next for ETH? - AMBCrypto News
PA Daily | Trump family project WLFI increases holdings of ETH, WBTC and MOVE; BTC whale with a cost price of nearly $10,000 is suspected of selling BTC - PANews
Medical Tech Firm BioNexus Gene Lab Announces New Ethereum-Focused Treasury Strategy - Cryptonews
Bionexus Gene Lab Corp (BGLC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.04%
0.11%
자본화:
|
볼륨(24시간):